Lisa A. Carey

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Supplementary Figure 1 from Identifying Locally Recurrent Versus Second Primary Breast Cancer: Genomic Versus Clinical Criteria from Carolina Breast Cancer Study Phase III

  2026-06-17

• Supplementary Table 2 from Identifying Locally Recurrent Versus Second Primary Breast Cancer: Genomic Versus Clinical Criteria from Carolina Breast Cancer Study Phase III

  2026-06-17

• Supplementary Figure 2 from Identifying Locally Recurrent Versus Second Primary Breast Cancer: Genomic Versus Clinical Criteria from Carolina Breast Cancer Study Phase III

  2026-06-17

• Supplementary Table 1 from Identifying Locally Recurrent Versus Second Primary Breast Cancer: Genomic Versus Clinical Criteria from Carolina Breast Cancer Study Phase III

  2026-06-17

• Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2)

  UNC Libraries · 2026-06-13

• Abstract 5955: Dissecting the enhancer logic in breast cancer metastasis through transcriptional, chromatin accessibility profiling and footprint-inferred transcription factor activity

  Cancer Research · 2026-04-03

• Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial

  ESMO Open · 2026-04-01

• Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial

  Annals of Oncology · 2025-12-12 · 11 citations

• Management of Cancer During Pregnancy: ASCO Guideline

  Journal of Clinical Oncology · 2025-12-11 · 8 citations

• Asparagine bioavailability governs metastasis in a model of breast cancer

  UNC Libraries · 2025-12-10

• Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers

  UNC Libraries · 2025-12-09

• Understanding metastasis mixed-treatment responses through genomic analyses.

  UNC Libraries · 2025-12-09

• B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancer

  UNC Libraries · 2025-12-09

• Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.

  UNC Libraries · 2025-12-09

• Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study

  UNC Libraries · 2025-12-02

• Identifying Locally Recurrent Versus Second Primary Breast Cancer: Genomic Versus Clinical Criteria from Carolina Breast Cancer Study Phase III

  Cancer Epidemiology Biomarkers & Prevention · 2025-12-01

• Data from Obesity and Breast Cancer Metastasis across Genomic Subtypes

  2025-11-26

• Supplementary Figure from Obesity and Breast Cancer Metastasis across Genomic Subtypes

  2025-11-26

• Supplementary Table from Obesity and Breast Cancer Metastasis across Genomic Subtypes

  2025-11-26

• Supplementary Table S5 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial

  2025-11-25